Professor Kamalinder K Singh

Kamalinder, as School Research Knowledge Exchange Lead, provides leadership for developing new interdisciplinary research programs and cross functional collaborations and guides the strategic development and integration of research within the School with other Schools at UCLan and other Universities at National and International level. She is Co-Director of our Biomedical evidence based Transdisciplinary (BEST) Health Research Institute which links basic and translational investigations at the bench to the patient focused research. Kamalinder is a member of various committees at the University level, including the University Research Knowledge exchange and ethics Committee, the University REF Strategy Group, the Pro Vice Chancellor’s Research and Knowledge exchange Strategy Group. Kamalinder teaches on the Master of Pharmacy and various MSc postgraduate courses.

With more than 35 years of experience in academia and research, Kamalinder has developed extensive expertise in the field of Advanced drug delivery, Nanomedicine, and Drug targeting with focus on formulation design, development, and evaluation of different biocompatible nanoparticle-based platform technologies including protein, lipid and hybrid nanoparticles and exploiting them to deliver drugs and genes across various biological barriers.

With expertise from laboratory to scale up development, she actively collaborates with pharmaceutical industry and has contributed significantly to patents, innovation and intellectual property. She is principal inventor on 18 patents, which include US, UK, Europe, China, Chile and India filings. She has authored more than 100 original research, review publications and book chapters. She is the invited member of International Steering Board of Handbook of Pharmaceutical Excipients, Royal Pharmaceutical Society of Great Britain, and American Pharmaceutical Association (from 2005-present) and contributed over 60 monographs to various editions of the Handbook.

She has edited a reference book on Nanoparticle Therapeutics: Production technologies, Types of Nanoparticles and regulatory aspects, Elsevier (2022). She is also co-editor of the books, NanoNutraceuticals, part of series on ‘Emerging trends in Nanobiomedicine’ Taylor and Francis, CRC Press (2019) and Nanopharmaceuticals, Vol 2 Nanobiomedicine Series, Studium Press (2015).

Kamalinder has supervised over 30 PhD students and has examined a similar number. She has been an invited speaker at numerous national and international conferences around the globe. Prior to joining us in 2013, Kamalinder was Professor of Pharmaceutics at SNDT Women’s University (SNDTWU), Mumbai, India and also served as Dean of the Pharmacy college within SNDTWU.